Minerva Neurosciences Q2 Adj. EPS $(0.10) Beats $(0.12) Estimate
Minerva Neurosciences (NASDAQ:NERV) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.12) by 9.09 percent. This is a 76.74 percent increase over losses of $(0.43) per share
Minerva Neurosciences lost less money per share than experts expected, and it's losing way less money than it did a year ago. When a company that's still losing money gets better at shrinking those losses, that's a sign things might be moving in a better direction.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.